Salt of CD 80 antagonist

Details for Australian Patent Application No. 2007217170 (hide)

Owner MediGene AG

Inventors Matthews, Ian Richard

Agent Davies Collison Cave

Pub. Number AU-B-2007217170

PCT Pub. Number WO2007/096588

Priority 0603522.4 22.02.06 GB

Filing date 19 February 2007

Wipo publication date 30 August 2007

Acceptance publication date 2 February 2012

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 19/00 (2006.01) Drugs for skeletal disorders

Event Publications

4 September 2008 PCT application entered the National Phase

  PCT publication WO2007/096588 Priority application(s): WO2007/096588

17 February 2011 Assignment before Grant

  MediGene Limited The application has been assigned to MediGene AG

2 February 2012 Application Accepted

  Published as AU-B-2007217170

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007217172-Pin servicing

2007217158-Mixed bacterial culture for atrazine degradation